Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

As China's Anti-monopoly Laws Go Into Effect, Rigorous Enforcement Could Apply To Deals On The Table

This article was originally published in PharmAsia News

Executive Summary

HONG KONG - New regulations that took effect this week help clarify a year-old Anti-monopoly Law in China but may be a prelude to more active enforcement by local authorities
Advertisement

Related Content

What Does China's Price Manipulation Ruling On Unilever Mean For Global Pharma? (Part 2 of 2)
What Does China's Price Manipulation Ruling On Unilever Mean For Global Pharma? (Part 2 of 2)
Novartis Tagged With Anti-monopoly Conditions In China For Alcon Acquisition
Pfizer Divests Its Swine Vaccine Business To Harbin Pharmaceutical Group In China As Condition Of $68 Billion Merger With Wyeth
Pfizer Divests Its Swine Vaccine Business To Harbin Pharmaceutical Group In China As Condition Of $68 Billion Merger With Wyeth
Advertisement
UsernamePublicRestriction

Register

SC077169

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel